Institut Rosell-Lallemand Launches New Formulation Synbiotic ProbioKid
The immune support range of Institut Rosell-Lallemand’s probiotic-based solutions now comprises two versions of ProbioKid — vanilla flavored and flavorless sachets, and a formula tailored for seniors and adults launched earlier this year under the name ProbioStim.
13/07/09 Following the success of ProbioKid, its clinically documented synbiotic, Institut Rosell-Lallemand has now developed a new flavorless formula. Available in a sachet format, ProbioKid is recommended to help maintain a balanced intestinal flora and a healthy immune system in children. The new formula has been developed to address consumers’ demand for a more versatile solution that can be administered to children with any food or drinks. First launched in 2003 in China, where it has met with growing success, ProbioKid has become the number one brand of children’s probiotic products in that country. It is also marketed by various partners in Europe, America, South Africa and Australia.
The gut is the site of 60-70% of the body’s immune defenses — the GALT (gut associated lymphoid tissue). ProbioKid contains a prebiotic (FOS) and an optimal combination of three well documented probiotic strains — L. Rosell-52, L. Rosell-71 and L. Rosell-33 — selected for their ability to act at the three levels of the gut’s immune defenses. A recent randomized, double-blind, placebo-controlled study conducted in partnership with Urgo, which distributes ProbioKid in France under the brand name Immunostim, demonstrated that ProbioKid could significantly reduce the relative risk of infectious disease in children during the winter season by 25% (p<0.045).
The immune support range of Institut Rosell-Lallemand’s probiotic-based solutions now comprises two versions of ProbioKid — vanilla flavored and flavorless sachets, and a formula tailored for seniors and adults launched earlier this year under the name ProbioStim.
To contact our editorial team please email us at editorial@cnsmedia.com
Subscribe now to receive the latest news directly into your inbox.